Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors

Journal of Nephrology

Volumn 20, Issue 5, 2007, Pages 588-595

  Lario, Sergio ^a   Bescós, Mónica ^a   Campos, Begoña ^a   Mur, Cristina ^a   Luque, Pilar ^a   Álvarez, Ricardo ^a   Campistol, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Experimental transplantation; Heme oxygenate; Ischemia reperfusion; Nitric oxide synthase; Thrombospondin; Transforming growth factor

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; METHYLPREDNISOLONE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; HEART BEAT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTOPERATIVE PERIOD; REAL TIME POLYMERASE CHAIN REACTION; RENAL GRAFT DYSFUNCTION; REPERFUSION INJURY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SWINE; UPREGULATION; ANIMAL; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; ISCHEMIA; KIDNEY; METABOLISM; METHODOLOGY; REPERFUSION; TIME;

ANIMALS; COLD ISCHEMIA; GENE EXPRESSION; HEME OXYGENASE-1; KIDNEY; KIDNEY TRANSPLANTATION; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; REPERFUSION; RNA, MESSENGER; SWINE; THROMBOSPONDIN 1; TIME FACTORS; UP-REGULATION; WARM ISCHEMIA;

EID: 38149096071     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sanchez-Fructuoso Al, de Miguel MM, Prats D, Barrientos A. Non-heart-beating donors: Experience from the Hospital Clinico of Madrid. J Nephrol 2003; 16: 387-92.
2. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-27.
3. Gueler F, Gwinner W, Schwarz A, Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney Int 2004; 66: 523-7.
4. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-33.
5. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002; 16: 1151-82.
6. Maxwell P. HIF-1: An oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003; 14: 2712-22.
7. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine. J Pharmacol Exp Ther 2000; 295:417-22.
8. Joles JA, Vos IH, Grone HJ, Rabelink TJ. Inducible nitric oxide synthase in renal transplantation. Kidney Int 2002; 61: 872-5.
9. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation 2002; 74: 905-12.
10. Lario S, Mendes D, Bescos M, Inigo P, Campos B, Alvarez R, Alcaraz A, Rivera-Fillat F, Campistol JM. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Transplantation 2003; 75: 1647-54.
11. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 2004; 65: 459-68.
12. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 1996; 148: 1851-60.
13. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002; 161: 831-9.
14. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-16.
15. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998; 93:1159-70.
16. Nijboer WN, Schuurs TA, van der Hoeven JA, Fekken S, Wiersema-Buist J, Leuvenink HG, Hofker S, Homan van der Heide JJ, van Son WJ, Ploeg RJ. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978-86.
17. Schuurs TA, Gerbens F, van der Hoeven JA, Ottens PJ, Kooi KA, Leuvenink HG, Hofstra RM, Ploeg RJ. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: Insights in the processes of brain death. Am J Transplant 2004; 4: 1972-81.
18. Lemos FB, Ijzermans JN, Zondervan PE, Peeters AM, van den ES, Mol WM, Weimar W, Baan CC. Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol 2003; 14: 3278-87.
19. Salahudeen AK. Cold ischemic injury of transplanted kidneys: New insights from experimental studies. Am J Physiol Renal Physiol 2004; 287: F181-7.
20. Gage FA, Vodovotz Y. Normalization of nitric oxide flux improves physiological parameters of porcine kidneys maintained on pulsatile perfusion. Nitric Oxide 2003; 9: 141-7.
21. Mitterbauer C, Schwarz C, Hauser P, Steininger R, Regele HM, Rosenkranz A, Oberbauer R. Impaired tubulointerstitial expression of endothelin-1 and nitric oxide isoforms in donor kidney biopsies with postischemic acute renal failure. Transplantation 2003; 76: 715-20.
22. Zhao XM, Hu Y, Miller GG, Mitchell RN, Libby P. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts. Circulation 2001; 103: 525-31.
23. Basile DP, Rovak JM, Martin DR, Hammerman MR. Increased transforming growth factor-beta I expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 1996; 270: F500-9.
24. Basile DP, Martin DR, Hammerman MR. Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF-beta in repair. Am J Physiol 1998; 275: F894-903.
25. Spurgeon KR, Donohoe DL, Basile DP. Transforming growth factor-beta in acute renal failure: Receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am J Physiol Renal Physiol 2005; 288: F568-77.
26. Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53:302-11.
27. Hochegger K, Knight S, Hugo C, Mayer G, Lawler J, Mayadas TN, Rosenkranz AR. Role of thrombospondin-1 in the autologous phase of an accelerated model of antiglomerular basement membrane glomerulonephritis. Nephron Exp Nephrol 2004; 96: e31-8.
28. Hugo C, Kang DH, Johnson RJ. Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model. Nephron 2002; 90: 460-70.
29. Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, Imai E, Hugo C. Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 2003; 163: 1185-92.
30. Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002; 61: 686-96.
31. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002; 61: 855-61.
32. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8-17.
33. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-66.